Found: 51
Select item for more details and to access through your institution.
Correction to: Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trial.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1407826
- By:
- Publication type:
- Article
Nasal Staphylococcus aureus Carriage and Antimicrobial Resistance Profiles Among Community-Dwelling Adults in Jiangsu, China.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 6, p. 1215, doi. 10.1007/s40121-024-00969-4
- By:
- Publication type:
- Article
Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6–17 Years: An Immunobridging Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 683, doi. 10.3390/vaccines12060683
- By:
- Publication type:
- Article
Characterization of whole genomes from recently emerging Mpox cases in several regions of China, 2023.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Vaccination with Adenovirus Type 5 Vector-Based COVID-19 Vaccine as the Primary Series in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Clinical Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 292, doi. 10.3390/vaccines12030292
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 1, p. 57, doi. 10.1007/s40121-023-00896-w
- By:
- Publication type:
- Article
Safety and Immunogenicity of Homologous Recombinant Adenovirus Type 5-Vectored COVID-19 Vaccine Booster Dose in Healthy Adults Aged 18–60 Years: a Single-Center, Open-Label Trial.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 12, p. 2757, doi. 10.1007/s40121-023-00892-0
- By:
- Publication type:
- Article
The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18–59 Years and over 60 Years Based on Two Randomized Controlled Trials in China.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1815, doi. 10.3390/vaccines11121815
- By:
- Publication type:
- Article
Inactivated SARS-CoV-2 Vaccine Booster Against Omicron Infection Among Quarantined Close Contacts.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 10, p. e2339507, doi. 10.1001/jamanetworkopen.2023.39507
- By:
- Publication type:
- Article
Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1083523
- By:
- Publication type:
- Article
Annual incidence and fatality rates of notifiable infectious diseases in southeast China from 1950 to 2022 and relationship to socioeconomic development.
- Published in:
- Journal of Global Health, 2023, v. 13, p. 1, doi. 10.7189/jogh.13.04107
- By:
- Publication type:
- Article
Influenza virus subtype/lineage-specific seasonal patterns and age-related infection risk, in Eastern China.
- Published in:
- Journal of Infection in Developing Countries, 2022, v. 16, n. 12, p. 1928, doi. 10.3855/jidc.14887
- By:
- Publication type:
- Article
AntiV‐SGN: a universal antiviral strategy to combat both RNA and DNA viruses by destroying their nucleic acids without sequence limitation.
- Published in:
- Microbial Biotechnology, 2022, v. 15, n. 9, p. 2488, doi. 10.1111/1751-7915.14076
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Recombinant Adenovirus Type-5–Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e783, doi. 10.1093/cid/ciab845
- By:
- Publication type:
- Article
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial.
- Published in:
- PLoS Medicine, 2022, v. 19, n. 5, p. 1, doi. 10.1371/journal.pmed.1003953
- By:
- Publication type:
- Article
Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.829665
- By:
- Publication type:
- Article
Evidence of the Efficacy and the Effectiveness of First Generation COVID-19 Vaccines in Clinical Trials and Real-world Studies.
- Published in:
- Zoonoses (2737-7466), 2022, v. 2, n. 1, p. 1, doi. 10.15212/ZOONOSES-2022-0025
- By:
- Publication type:
- Article
Rapid and Sensitive Detection of Salmonella spp. Using CRISPR-Cas13a Combined With Recombinase Polymerase Amplification.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.732426
- By:
- Publication type:
- Article
Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2.
- Published in:
- 2021
- By:
- Publication type:
- Letter
COVID‐19 outbreak following a single patient exposure at an entertainment site: An epidemiological study.
- Published in:
- Transboundary & Emerging Diseases, 2021, v. 68, n. 2, p. 773, doi. 10.1111/tbed.13742
- By:
- Publication type:
- Article
Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need.
- Published in:
- Signal Transduction & Targeted Therapy, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41392-021-00481-y
- By:
- Publication type:
- Article
Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.595970
- By:
- Publication type:
- Article
Quorum sensing regulation confronts the development of a viable but non‐culturable state in Vibrio cholerae.
- Published in:
- Environmental Microbiology, 2020, v. 22, n. 10, p. 4314, doi. 10.1111/1462-2920.15026
- By:
- Publication type:
- Article
Serotype specific epitopes identified by neutralizing antibodies underpin immunogenic differences in Enterovirus B.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18250-w
- By:
- Publication type:
- Article
Structures of Echovirus 30 in complex with its receptors inform a rational prediction for enterovirus receptor usage.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18251-9
- By:
- Publication type:
- Article
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Editorial: Hepatitis B virus infection and risk of nonalcoholic fatty liver disease: A population‐based cohort study‐authors' reply.
- Published in:
- Liver International, 2020, v. 40, n. 6, p. 1502, doi. 10.1111/liv.14396
- By:
- Publication type:
- Article
A case-control study on the risk factors for hemorrhagic fever with renal syndrome.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immunogenicity and Safety of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase 3 Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 10, p. N.PAG, doi. 10.1093/ofid/ofz380
- By:
- Publication type:
- Article
A Cluster of Bunyavirus-Associated Severe Fever With Thrombocytopenia Syndrome Cases in a Coastal Plain Area in China, 2015: Identification of a Previously Unidentified Endemic Region for Severe Fever With Thrombocytopenia Bunyavirus.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 6, p. 1, doi. 10.1093/ofid/ofz209
- By:
- Publication type:
- Article
Rapid detection of human mastadenovirus species B by recombinase polymerase amplification assay.
- Published in:
- BMC Microbiology, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12866-018-1365-7
- By:
- Publication type:
- Article
Hepatitis B virus infection and risk of non‐alcoholic fatty liver disease: A population‐based cohort study.
- Published in:
- Liver International, 2019, v. 39, n. 1, p. 70, doi. 10.1111/liv.13933
- By:
- Publication type:
- Article
Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance and seroconversion in hepatitis B e antigen‐negative chronic infection patients: A population‐based prospective cohort.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 12, p. 1588, doi. 10.1111/jvh.12978
- By:
- Publication type:
- Article
Identification and genetic characterization of a novel circular single-stranded DNA virus in a human upper respiratory tract sample.
- Published in:
- Archives of Virology, 2017, v. 162, n. 11, p. 3305, doi. 10.1007/s00705-017-3481-3
- By:
- Publication type:
- Article
Preliminary fast diagnosis of severe fever with thrombocytopenia syndrome with clinical and epidemiological parameters.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0180256
- By:
- Publication type:
- Article
Multiplex Reverse-Transcription Loop-Mediated Isothermal Amplification Coupled with Cascade Invasive Reaction and Nanoparticle Hybridization for Subtyping of Influenza A Virus.
- Published in:
- Scientific Reports, 2017, p. 44924, doi. 10.1038/srep44924
- By:
- Publication type:
- Article
2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Fine mapping the MHC region identified four independent variants modifying susceptibility to chronic hepatitis B in Han Chinese.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 6, p. 1225, doi. 10.1093/hmg/ddw003
- By:
- Publication type:
- Article
Comparing the Primary and Recall Immune Response Induced by a New EV71 Vaccine Using Systems Biology Approaches.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140515
- By:
- Publication type:
- Article
A Booster Dose of an Inactivated Enterovirus 71 Vaccine in Chinese Young Children: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
- Published in:
- Journal of Infectious Diseases, 2014, v. 210, n. 7, p. 1073, doi. 10.1093/infdis/jiu113
- By:
- Publication type:
- Article
The Cross-Neutralizing Activity of Enterovirus 71 Subgenotype C4 Vaccines in Healthy Chinese Infants and Children.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079599
- By:
- Publication type:
- Article
Conserved epitopes dominate cross- CD8<sup>+</sup> T-cell responses against influenza A H1 N1 virus among Asian populations.
- Published in:
- European Journal of Immunology, 2013, v. 43, n. 8, p. 2055, doi. 10.1002/eji.201343417
- By:
- Publication type:
- Article
Development and Evaluation of a Pseudovirus-Luciferase Assay for Rapid and Quantitative Detection of Neutralizing Antibodies against Enterovirus 71.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0064116
- By:
- Publication type:
- Article
Surveillance of 16 respiratory viruses in patients with influenza-like illness in Nanjing, China.
- Published in:
- Journal of Medical Virology, 2012, v. 84, n. 12, p. 1980, doi. 10.1002/jmv.23401
- By:
- Publication type:
- Article
Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China.
- Published in:
- Virology Journal, 2012, v. 9, n. 1, p. 248, doi. 10.1186/1743-422X-9-248
- By:
- Publication type:
- Article
Seroprevalence of Pandemic (H1N1) 2009 in Pregnant Women in China: An Observational Study.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017995
- By:
- Publication type:
- Article
Profile of Acute Infectious Markers in Sporadic Hepatitis E.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013560
- By:
- Publication type:
- Article
Characterization of enterohemorrhagic Escherichia coli O157:H7 00B015: a Shiga toxin producing but virulence-attenuated isolate.
- Published in:
- Canadian Journal of Microbiology, 2010, v. 56, n. 8, p. 651, doi. 10.1139/W10-049
- By:
- Publication type:
- Article